TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scanfarma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
6,614
|
6,703
|
6,938 |
| Financial expenses |
0
|
4
|
1 |
| Earnings before taxes |
-2,072
|
504
|
373 |
| EBITDA |
-2,059
|
483
|
372 |
| Total assets |
2,854
|
5,048
|
5,346 |
| Current assets |
2,704
|
4,876
|
5,346 |
| Current liabilities |
609
|
590
|
974 |
| Equity capital |
942
|
3,093
|
2,758 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
3
|
5
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.0%
|
61.3%
|
51.6% |
| Turnover per employee |
2,205
|
1,341
|
1,156 |
| Profit as a percentage of turnover |
-31.3%
|
7.5%
|
5.4% |
| Return on assets (ROA) |
-72.6%
|
10.1%
|
7.0% |
| Current ratio |
444.0%
|
826.4%
|
548.9% |
| Return on equity (ROE) |
-220.0%
|
16.3%
|
13.5% |
| Change turnover |
132
|
-270
|
-857 |
| Change turnover % |
2%
|
-4%
|
-11% |
| Chg. No. of employees |
-2
|
-1
|
-1 |
| Chg. No. of employees % |
-40%
|
-17%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.